HIF1A and cancer: Our observations that tamoxifen can negatively regulate HIF‐1A in cancer cells through a hypoxia‐independent mechanism open up the possibility to reprogram the mechanosensory machinery in these cells to modulate their proliferation under hypoxic conditions by targeting HIF‐1A.